Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.96
+0.91 (2.67%)
Jul 21, 2026, 12:27 PM EDT - Market open
Roivant Sciences Employees
Roivant Sciences had 721 employees as of March 31, 2026. The number of employees decreased by 29 or -3.87% compared to the previous year.
Employees
721
Change (1Y)
-29
Growth (1Y)
-3.87%
Revenue / Employee
$11,456
Profits / Employee
-$415,771
Market Cap
25.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 721 | -29 | -3.87% |
| Mar 31, 2025 | 750 | -158 | -17.40% |
| Mar 31, 2024 | 908 | 4 | 0.44% |
| Mar 31, 2023 | 904 | 41 | 4.75% |
| Mar 31, 2022 | 863 | 198 | 29.77% |
| Jun 30, 2021 | 665 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
ROIV News
- 5 days ago - Arbutus initiates patent infringement actions against Pfizer, BioNTech - TheFly
- 6 weeks ago - Roivant Sciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Roivant Sciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Roivant Sciences Transcript: Bernstein 42nd Annual Strategic Decisions Conference - Transcripts
- 7 weeks ago - Roivant Sciences price target raised to $40 from $35 at JPMorgan - TheFly
- 2 months ago - Roivant Sciences price target raised to $36 from $30 at Guggenheim - TheFly
- 2 months ago - Roivant Sciences price target raised to $31.50 from $29.50 at BofA - TheFly
- 2 months ago - Roivant Sciences price target raised to $41 from $38 at TD Cowen - TheFly